Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-465

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51655-465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 465 52)

The text is describing Atorvastatin Calcium Tablets with a strength of 40mg, containing calcium USP equivalent to Atorvastatin. The package contains 30 tablets and it should be stored at a temperature range of 20° - 25°C. It is repackaged by Northwind Pharmaceuticals and the product can only be obtained with a valid prescription. The remaining details are lot and manufacturing information which could not be interpreted.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

The given text appears to be a chart showing the cumulative incidence percentage of Atorastatn and Placsbo over a period of 35 years. The HR and p-values are also listed.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

This is a graph showing the cumulative hazard percentage for a placebo and atorvastatin. It shows the hazard ratio at 0.63 with a confidence interval between 0.48 and 0.83 and a p-value of 0.001. The x-axis shows the time to the first primary endpoint through four years of follow-up.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

The data presented shows the percentage of subjects who experienced a major cardiovascular event while taking different doses of Atorvastatin. The results show that at a dose of 10mg, there were no events recorded. At a dose of 80mg, there was a lower risk of experiencing an event compared to the control group, as indicated by a hazard ratio of 0.78 and a P value of 0.0002. The graph displays the time to the first major cardiovascular endpoint in years.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.